SUBSCRIBE
SUBSCRIBE

Missouri

Signage outside Express Scripts' headquarters in Missouri
Pharmacy benefit managers
Cigna to Remove AbbVie’s Humira From Formularies, Putting More Pressure on Blockbuster
Mirroring fellow pharmacy benefit manager CVS Caremark, Cigna’s Express Scripts is taking Humira off its major commercial formularies starting next year and focusing on more affordable biosimilar options.
August 27, 2024
 · 
2 min read
 · 
Tristan Manalac
PRESS RELEASES
Press Releases
CENTENE CORPORATION REPORTS THIRD QUARTER 2025 RESULTS
October 29, 2025
 · 
32 min read
Press Releases
Geneoscopy’s Scrape-Free Collection Method for Colorectal Cancer Screening Validated by New Data and Peer-Reviewed Publication
October 23, 2025
 · 
4 min read
Press Releases
MediBeacon receives regulatory approval to sell the Transdermal GFR System in China
October 22, 2025
 · 
5 min read
Press Releases
Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025
October 22, 2025
 · 
1 min read
Press Releases
Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs
October 16, 2025
 · 
4 min read
Press Releases
Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias
October 14, 2025
 · 
4 min read
Press Releases
Amplifi Vascular Announces Successful First-in-Human Study Results, Closes $6.8M Series A, and Receives FDA IDE Approval
October 9, 2025
 · 
2 min read
Press Releases
Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference on October 11, 2025
October 7, 2025
 · 
5 min read
Press Releases
C2N Submits U.S. FDA Regulatory Filing for Its Alzheimer’s Disease Blood Test
October 2, 2025
 · 
5 min read
Press Releases
New Research Reinforces C2N’s PrecivityAD2™ Blood Test as a Highly Accurate Tool to Detect Brain Amyloid Pathology in Symptomatic Patients
September 25, 2025
 · 
4 min read
Press Releases
LPOXY Initiates $28M Series A Financing with 5 Horizons Ventures to Fund STOP-Cdiff Pivotal Trial
September 3, 2025
 · 
3 min read
Press Releases
Dynamic Growth Leads C2N Diagnostics to Expand St. Louis Headquarters to Meet Global Need for Answers to Alzheimer’s Disease
September 3, 2025
 · 
5 min read
Press Releases
Stereotaxis Technology to be Featured at Heart Rhythm Society’s HRX 2025
August 29, 2025
 · 
3 min read
Press Releases
Wugen Secures $115 Million to Advance Pivotal Study of First-in-Class Allogeneic CAR-T Therapy, WU-CART-007
August 28, 2025
 · 
5 min read
Press Releases
Stereotaxis Reports 2025 Second Quarter Financial Results
August 8, 2025
 · 
9 min read
Press Releases
C2N Announces Major Global Expansion, Adds Six New International Partners
August 8, 2025
 · 
4 min read
Press Releases
Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter
July 29, 2025
 · 
4 min read
Press Releases
CENTENE CORPORATION REPORTS SECOND QUARTER 2025 RESULTS
July 25, 2025
 · 
30 min read
Press Releases
MilliporeSigma and Washington University in St. Louis Sign MoU to Advance Scientific Collaboration
July 25, 2025
 · 
4 min read
Press Releases
Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025
July 24, 2025
 · 
1 min read
Load More